View Video Duration: 1 hour 28 minutes
Fulfilling the promise of genomics in improving health requires a population perspective to complement the “bench to bedside” model of clinical translation. An expanded multidisciplinary research agenda is needed to understand the benefits, costs, and harms of genomics in health care and disease prevention (beyond bench to bedside) in the larger context of social and environmental determinants of disease.
Commentator:
Dr. Douglas Yee, MD
Director, Masonic Cancer Center
University of Minnesota